From: Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
c
α
ω
0.4
0.0067
0.822
0.5
0.0084
0.826
0.6
0.0104
0.830
0.7
0.0127
0.835
0.8
0.0153
0.841